Alexza Pharma (ALXA) Resubmits NDA for ADASUVE, Remains On Schedule for Early Q3 EMA Submission

Go back to Alexza Pharma (ALXA) Resubmits NDA for ADASUVE, Remains On Schedule for Early Q3 EMA Submission